Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
If someone's always late, is it time blindness, or are they just being rude? - 2Heavy rain, floods kill at least 45 people in Afghanistan, Pakistan
- 3Ukraine confirms defence and energy ministers at second attempt
- 4Trouvez La Carte De Cr\u00e9dit Id\u00e9ale Pour Vos Besoins En Belgique
- 5Top notch Remote Earphones for Audiophiles
- Pick Your Number one Sort Of Music
- Vacation destinations in America
- Australians told to continue Easter travel plans despite fuel shortages
- The Best Computer games for Multiplayer Fun
- Nodding off is dangerous. Some animals have evolved extreme ways to sleep in precarious environments
- Home Mechanization Frameworks for Brilliant Residing
- Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion
- 10 Delectable Specialty Mixed drinks
- See the 'amazing' photos of Earth taken on historic Artemis II moon mission
